<p>AML, acute myeloid leukemia; ALL, acute lymphocytic leukemia; CML, chronic myeloid leukaemia; CLL, chronic lymphocytic leukemia; HWE, <i>P</i> value of Pearson’s goodness-of-fit χ2 test for Hardy-Weinberg equilibrium; QA, quality assessment; Unknown, including study populations in which the race was mixed/unclear or tumor type was not described.</p
<p>MM: multiple myeloma; SMM: smouldering myeloma; M: melphalan; P: prednisone; ZLD: zoledronic acid...
<p>Abbreviations: AML, acute myeloid leukaemia; ALL, acute lymphoblastic leukaemia.</p>*<p>statistic...
In this study, the survival rates of acute lymphocytic leukemia patients and how they differ based o...
<p>AML: acute myeloid leukemia; P<sub>h</sub>: p-value of heterogeneity test; CI: confidence interva...
<p>ALL: acute lymphoid leukemia; AML: acute myelogenous leukemia;</p><p>*: GWAS-1;</p>#<p>: GWAS-2.<...
<p>CML: chronic myeloid leukemia; NHL: non-hodgkin lymphoma; HL: hodgkin lymphoma; NSCLC: non small ...
<p>HNSCC head and neck squamous cell carcinoma, NR not reported, AML acute myeloid leukemia, SA Sout...
<p>Meta-analysis for the association of acute myeloid leukemia risk with <i>MTHFR</i> C677T polymorp...
<p><i>MTHFR</i>, methylenetetrahydrofolate reductase; OR, odds ratio; CI, confidence interval; vs., ...
<p><i>MTHFR</i>, methylenetetrahydrofolate reductase; OR, odds ratio; CI, confidence interval; vs., ...
Background: The goal of this study concerned the pretherapeutic identification of high-risk acute my...
<p>n, number of studies; unknown, including study populations in which the race was mixed or unclear...
<p>HWE, Hardy-Weinberg equilibrium; NR, not reported; Cases, MI patients; HCC, hospital based case-c...
<p>N: number of studies included; OR: odds ratio; Ph: p value for heterogeneity; BC: breast cancer; ...
<p>AML, acute myeloid leukemia; ALL, acute lymphoid leukemia; NHL, lymphoma; HD, Hodgkin’s disease; ...
<p>MM: multiple myeloma; SMM: smouldering myeloma; M: melphalan; P: prednisone; ZLD: zoledronic acid...
<p>Abbreviations: AML, acute myeloid leukaemia; ALL, acute lymphoblastic leukaemia.</p>*<p>statistic...
In this study, the survival rates of acute lymphocytic leukemia patients and how they differ based o...
<p>AML: acute myeloid leukemia; P<sub>h</sub>: p-value of heterogeneity test; CI: confidence interva...
<p>ALL: acute lymphoid leukemia; AML: acute myelogenous leukemia;</p><p>*: GWAS-1;</p>#<p>: GWAS-2.<...
<p>CML: chronic myeloid leukemia; NHL: non-hodgkin lymphoma; HL: hodgkin lymphoma; NSCLC: non small ...
<p>HNSCC head and neck squamous cell carcinoma, NR not reported, AML acute myeloid leukemia, SA Sout...
<p>Meta-analysis for the association of acute myeloid leukemia risk with <i>MTHFR</i> C677T polymorp...
<p><i>MTHFR</i>, methylenetetrahydrofolate reductase; OR, odds ratio; CI, confidence interval; vs., ...
<p><i>MTHFR</i>, methylenetetrahydrofolate reductase; OR, odds ratio; CI, confidence interval; vs., ...
Background: The goal of this study concerned the pretherapeutic identification of high-risk acute my...
<p>n, number of studies; unknown, including study populations in which the race was mixed or unclear...
<p>HWE, Hardy-Weinberg equilibrium; NR, not reported; Cases, MI patients; HCC, hospital based case-c...
<p>N: number of studies included; OR: odds ratio; Ph: p value for heterogeneity; BC: breast cancer; ...
<p>AML, acute myeloid leukemia; ALL, acute lymphoid leukemia; NHL, lymphoma; HD, Hodgkin’s disease; ...
<p>MM: multiple myeloma; SMM: smouldering myeloma; M: melphalan; P: prednisone; ZLD: zoledronic acid...
<p>Abbreviations: AML, acute myeloid leukaemia; ALL, acute lymphoblastic leukaemia.</p>*<p>statistic...
In this study, the survival rates of acute lymphocytic leukemia patients and how they differ based o...
DOI
Add to ORKG